PO.5.105 The effect of belimumab on extra-renal outcomes: results from the phase 3, randomised, placebo-controlled, 104-week bliss-ln study in patients with active lupus nephritis

DOI Open Access

Journal

Details 詳細情報について

Report a problem

Back to top